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Abstract Sudden cardiac death is one of the main causes of mortal i ty in patients wi th structural heart disease. Al though an 
implantable cardioverter defibri l lator significantly reduces the mortal i ty rate, many patients newer receive a shock. 
Identification of high-risk patients wou ld reduce the costs associated w i th this therapy and prevent the deleterious 
effect o f inappropriate discharges. As scar tissue is the substrate of ventricular arrhythmias in patients wi th structural 
heart disease, scar characterization could al low stratification o f the risk. The objective of this article is t o review the 
role o f scar characteristics in the pathogenesis o f ventricular arrhythmias in patients wi th structural heart disease. 
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This ar t ic le is p a r t o f t h e Spot l ight Issue o n : Reducing the I m p a c t o f Myocard ia l I s c h a e m i a / R e p e r f i i s i o n Injury 
1. Introduction 
Monomorphic ventricular tachycardia (MVT) in patients wi th structural 
heart disease can be caused by several mechanisms (e.g. bundle branch 
re-entry, fascicular re-entry, and automatism f rom cells located at the 
border o f the scar o r in the His-Purk in je system); however, most are 
caused by myocardial scar re-entry. Although myocardial scars can 
also appear during the evolution of right ventricular cardiomyopathy 
and congenital heart disease, this review examines the processes 
associated w i th left ventricular scars, namely ischaemic heart disease 
and non-ischaemic cardiomyopathy. In this article, in o rder t o obtain 
accurate information on the scar dimension and heterogeneity o f the 
scar, we wi l l review the literature regarding the characteristics o f the 
scar using three-dimensional (3D) navigation systems and contrast 
(gadoltnium)-enhanced magnetic resonance imaging (ceMRl). 
2. Ventricular tachycardia substrate 
in patients with ischaemic heart disease 
2.1 Slow conduction determinants 
2.1.1 G a p junct ion changes 
The mechanism underlying sustained MVT in patients wi th chronic 
myocardial infarction is a re-entry in which the slow conduct ion 
pathways are composed o f bundles o f viable myocytes embedded in 
regional scars. These surviving myocytes join t o create corr idors 
that reach the border of the scar and connect to normal tissue.1 
The development of slow conduction pathways involves processes 
linked t o cardiac remodell ing, such as cardiac fibrosis,2 which acts 
on surviving myocytes and leads to cell disconnection and zigzag con-
duct ion. " Cell connection depends on the integrity o f gap junctions, 
which permi t the passage of intracellular ions between cells. Gap junc-
tions are formed by t w o connexons, one f rom each connected cell, 
which migrate f rom the Golgi apparatus t o the intercalated disks 
and bind end t o end w i th connexons f rom apposing cells. The 
factors affecting gap junctions and contr ibut ing t o cell disconnection 
and format ion of the anatomical substrate o f ventricular arrhythmias 
are reduced expression of connexin (Cx) 43, which is commonly 
observed after myocardial infarction,5 and misallocation o f connex-
ons. The turnover o f gap junctions is very fast, because the half-life 
of Cx43 is as short as 2—5 h,^ thus facilitating misallocation of a con-
nexon in the membrane in patients wi th heart diseases such as myo-
cardial infarction. The membrane signals that attract connexons t o 
intercalated disks may be shifted to the lateral membrane, thus direct-
ing them towards the lateral non-disc sarcolemmal membrane. A l -
though these alterations in gap junct ion distr ibution may contr ibute 
t o slow electrical conduct ion, their role is probably a minor one, 
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because conduction velocity slows only when Cx43 is reduced by 
70 -95%, but not by 50%.B This observation suggests that the reduc-
t ion of Cx43 expression in patients wi th heart disease is probably not 
enough to reduce conduction velocity. In fact, deposit ion of collagen 
between myocytes may be required t o slow conduction. A recent 
study suggested that only the synergism between sodium current re-
duct ion, along w i th increased fibrosis and impaired intercellular coup-
ling, could lead to a marked decrease in conduct ion velocity. 
Therefore, simply reducing gap junctions is not enough to slow con-
duct ion, and interaction between surviving myocytes and cardiac f i -
brosis seems t o be necessary for the development of ventricular 
tachycardia (VT) substrate. 
2.1.2 Fibroblasts and cardiac fibrosis 
The heart is formed by different types o f cells, mainly myocytes and 
fibroblasts. In some species, fibroblasts account f o r more than half 
of all heart cells and produce the extracellular matrix (ECM), which 
is composed o f several types of collagen, as wel l as f ibronectin. The 
main role o f the ECM is t o create the scaffold for cardiomyocytes.11 
Cardiac fibroblasts and the ECM form a network t o which the myo-
cytes attach, and which helps t o maintain the structural integrity o f the 
heart while, at the same t ime, enabling fibroblasts t o exert mechanical 
forces on the myocytes.12 Cardiac fibroblasts are not isolated cells, 
because they can connect t o o ther fibroblasts and myocytes by 
Cx45 and Cx43, as observed at homocellular and hete roce Ilutar junc-
tions. ' Mechanical stress and chemical signalling can activate 
cardiac fibroblasts after a cardiac injury, thus starting the remodell ing 
process. The cardiac fibroblasts that, up t o this point, have synthesized 
and degraded the ECM in such away that they have maintained a f i rm 
equil ibrium, begin t o increase the product ion o f ECM that surrounds 
myocytes, thus disrupting cell connections, and generating electrical 
barriers that give rise t o the discontinuous conduction that reduces 
conduction velocity, 
Remodelling not only implies an increase in ECM product ion, but 
also important changes in f ibroblast phenotype. Af ter heart injury, 
some fibroblasts express smooth muscle cell proteins that are not 
normally expressed in fibroblasts, such as a-smooth muscle actin. 
Fibroblasts w i th smooth muscle cell characteristics are called myofi-
broblasts. This phenotype change has the fol lowing t w o importance 
consequences: (i) the contracti le proteins that facilitate the healing 
process can also transmit mechanical tension to the myocytes; and 
(¡i) myofibroblasts have higher Cx43 levels than fibroblasts, w i th the 
result that electrical coupling between isolated myocytes and myofi-
broblasts increases.17 This observation is important, because contacts 
between fibroblasts and cardiomyocytes in intact and healthy hearts 
are weak.13 Consequently, myofibroblasts have a significantly 
greater ability than fibroblasts t o modify the electrophysiological char-
acteristics of myocytes. 
2.1.3 Effects o f the in teract ion b e t w e e n myocytes and 
myof ibroblasts 
Myofibroblasts are present in post-infarction scars in humans. They 
have been found as early as 4 - 6 days after infarction, and seem t o 
persist for many years. As mentioned above, myofibroblasts can 
express Cx43 and Cx45, both among themselves and w i th cardio-
myocytes. Consequently, the presence of these connexins enables 
electrical current t o pass between myocytes and myofibroblasts. A l -
though myofibroblasts do not express sodium channels, membrane 
resistance is so high that electrotonic current can f low between non-
connected myocytes through fibroblast bridges over extended dis-
tances.20 The electrical current f lowing through connections 
between myocytes and fibroblasts causes a gradual decline in 
myocyte resting membrane potential, because fibroblasts are less 
polarized. Therefore, fibroblasts can partly depolarize myocytes into 
the range of sodium channel inactivation, thus producing slowing of 
conduction. Myofibroblast contract ion, which plays a key role in 
healing, may also cause slowing o f conduction in scar areas after a 
myocardial infarction. Myofibroblasts can contract and transmit the 
contracti le force to myocytes, thus activating mechanosensitive chan-
nels. The activation of mechanosensitive channels depolarizes the car-
diomyocyte membrane and inactivates sodium channels. 
The above findings suggest the electro-anatomical interaction 
between surviving myocytes, fibrosis, and fibroblasts/myofibroblasts 
wi th in the scar, which generates slow conduct ion pathways that 
fo rm part o f the re-entrant circuit. Therefore, characterization of 
the scar and the surviving myocytes could enable us t o stratify the 
risk of arrhythmia after myocardial infarction. 
2.2 Voltage mapping scar characteristics in 
patients with ventricular arrhythmias 
As VT substrate is intimately related t o surviving myocytes inside the 
scar, characterization of the VT substrate relies on identif ication o f 
the scar. Scars are areas w i th few myocytes where f ibrous tissue pre-
vails; consequently, local electrograms recorded at these sites are 
characterized by lower voltage amplitude than electrograms recorded 
in normal tissue. Scar areas can be identified according to the elec-
t rogram amplitude measured during catheter mapping and delimited 
using navigation systems that permit the 3D reconstruction of the 
endocardial o r epicardial surface o f the cardiac chambers and 
project the voltage o f the electrograms at the corresponding site 
on the surface. The resulting voltage maps can be visualized and ana-
lysed on a computer display. The voltage o f the local electrogram is 
colour coded and can be adjusted according to different definitions 
o f scar tissue (figure i A). Animal and human studies have identified 
the voltage cut-off that differentiates the electrograms recorded in 
norma! and scar tissues. ' A voltage > 1.5 mV distinguishes 
normal myocardium f rom scar, and the scar itself can be differentiated 
into dense scar (<0 .5 mV) and scar border ( > 0 . 5 and <1.5 mV). 
These voltage limits have been used t o establish a direct correlat ion 
between the extension o f the scar in voltage maps and anatomical 
preparations.2 '1 Slow conduct ion areas within the scar are easily 
recognized during endocardial mapping by recording the electrograms 
w i th isolated components o r late potentials (E-OLP) . 2 É IC and LP are 
components o f the electrogram that are recorded beyond the end o f 
the QRS and separated f r o m the main component o f the electrogram 
by an isoelectric line. Several studies have established the relationship 
between E-IC/LP and VT isthmuses. ' IC/LP are not homogeneous-
ly dispersed around the scar, but located in specific areas. Around 
70% o f E-IC/LP fo rm slow conduct ion channels (CC), • which are 
areas inside the scar that are differentiated f r o m the surrounding 
scar by a higher voltage. These structures are easily identified in 
voltage maps by carefully adjusting the voltage threshold that 
defines the scar (figure i B). ' This observation emphasizes a deter-
minant characteristic o f the scar, namely, the scar is not a homoge-
neous structure, but clearly a heterogeneous structure whose 
heterogeneity is related t o surviving fibres. Therefore, heterogeneity 
is intimately related to arrhythmogenesis, as illustrated by ultrahigh-
Á. Arenal et al 
Stags. Bawftna 









J I li 
3ml/ 






F i g u r e I (A) Voltage map showing a scar in a patient with previous inferior myocardial infarction. The colour range represents the electrogram 
voltage amplitude. Dense scar is shown in red (electrogram amplitude <0.5 mV). (S) Voltage map showing the heterogeneity of the scar and con-
duction channels. This view of the inferior wall of the left ventricle shows a voltage map during right ventricular apical pacing, when the voltage that 
defined the scar was set at 0.2 mV. At this voltage, a channel spans from the septum to the lateral wall. The electrogram recorded at sites identified by 
white numbers is shown on the left of the paneL This figure shows the heterogeneous nature of the scar. Electrograms with a higher amplitude are 
inside the scar (electrograms 2 -6 ) ; the / usually present isolated components or late potentials (IC/LP), and are associated with the formation of 
conduction channels. Reproduced with permission from reference 28. 
density mapping w i th mult ipolar catheters, showing that E-IC/LP that 
are critical t o re-entry are adjacent t o heterogeneous islets.30 C C and 
E - O L P are sensitive and specific markers o f VT substrate in ischaemic 
patients. Recent studies show that E-iC/LPs are found in more than 
90% of V T isthmuses.26 '27,31 In addit ion, Haqqani et of.32 reported 
that C C within dense scar tissue and adjacent t o the mitral annulus 
and E-IOLP were more frequently observed in sustained MVT 
patients than in con t ro l patients, despite similar left ventricle (LV) 
parameters, such as ejection fraction (EF). 
These studies highlight an important finding, namely, that scar is not 
a homogeneous tissue, because some areas have a higher voltage 
owing to the presence of surviving fibres. These areas are corr idors 
o f slow conduct ion that can f o r m part of re-entrant circuits. There-
fore, ventricular arrhythmias are mainly due to scar heterogeneity. 
2.3 Characterization of the scar by MRI 
Contrast (gadolinium)-enhanced magnetic resonance imaging (ceMRI) 
can accurately identify and delimit myocardial infarction in both 
animals and humans. Gadolinium is trapped by f ibrous tissue, 
thus generating the higher signal intensity (SI) observed in MR 
images. In humans, an SI above 2 SD of the mean remote normal myo-
cardium SI can be used to identify the infarct. Signal intensity differ-
entiates t w o areas wi th in the scan (i) the core area, defined by an SI 
> 3 SD above the remote normal myocardium SI; and (ii) the 
heterogeneous tissue (HT) o r grey zone that contains the surviving 
myocytes mixed w i th f ibrous tissue and that is defined by an SI of 
between 2 and 3 SDs35 (Figure 2). The presence o f viable myocytes 
causes the lower SI of the HT. 
2.3.1 Scar characterist ics and V T inducibil ity 
Several studies have shown the association between non-invasively 
detected scar size and architecture and bo th inducible and spontan-
eous MVT. Bello et of.3'1 reported that the Infarct size and morphology 
detected by ceMRI is a better predictor of VT inducibility than LVEF. 
The authors studied 48 patients w i th known coronary artery disease 
w h o were referred for electrophysiological study using ceMRI. Scar 
characteristics we re determined and compared between patients 
wi th no inducible VT, those wi th inducible MVT, and those w i th indu-
cible ventricular fibri l lation. Patients wi th MVT had larger infarcts than 
patients w h o did not have inducible arrhythmias. Patients w i th poly-
morphic VT/fibri l lat ion had intermediate values. Logistic regression 
demonstrated that infarct mass and surface area were better predic-
tors of inducibility o f MVT than LVEF. Both size and characteristics of 
the scar are related t o inducibility o f MVT. Schmidt et al. reported 
that H T mass detected by MRI was the best predictor of VT induci-
bility. VT inducibility was tested before implantation of an implantable 
cardioverter defibri l lator (!CD) for primary prevention in 47 patients 
w h o underwent ceMRI. W h e n inducible and non-inducible patients 
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F i g u r e 2 Identifcation of scar, dense scar, and heterogeneous tissue based on measurement of signal intensity (SI) using contrast 
(gadolinium)-enhanced magnetic resonance imaging (ceMRI). This ceMRI long axis view shows the anteroseptal infarct as high SI (area inside the con-
tinuous line) and the normal myocardium as dark SI. Heterogeneous tissue was defined using the following process: (i) the endocardial and epicardial 
borders were drawn: and (ii) a region of interest in the remote non-infarcted myocardium and the normal SI was defined (site 2). The myocardial 
segment with an SI > 2 SD of the infarcted region was loosely outlined. Heterogeneous tissue (sites 3 and 4) can be differentiated inside the infarcted 
area (SI > 2 SD < 3 SD) and dense scar (Sl>3 SD; site 5). 
were compared, no differences were observed between LVEF, LV 
end-diastolic volume, and infarct size. Nevertheless, H T mass was sig-
nificantly higher in inducible patients, and was the only significant pre-
dictor in stepwise logistic regression analysis. 
2.3.2 Scar characteristics and prognosis af ter myocard ia l 
infarct ion 
N o t only is scar characterization useful f o r differentiating patients wi th 
inducible VT, it can also establish outcome after myocardial infarction. 
Yan et of.35 studied 144 patients wi th documented coronary artery 
disease and abnormal myocardial delayed enhancement consistent 
w i th post-infarction scar. Based on the SI, the authors measured the 
to ta l infarct size and divided it between the scar core and HT. After 
a median fol low-up o f 2.4 years, 29 (20%) patients died. Patients 
w i th an above-median HT/infarct size quot ient were at higher risk 
f o r death than those wi th a below-median HT/infarct size. Left ven-
tr icular systolic volume index and HT/infarct size were the strongest 
predictors of all-cause mortal i ty and cardiovascular mortal i ty in a 
multivariate analysis. Moreover, HT/infarct size maintained the inde-
pendent associations "with all-cause and cardiovascular mortal i ty 
after adjusting fo r age and LVEF. 
These studies demonstrated that tissue heterogeneity is present 
and quantifiable in human infarcts. More extensive tissue heterogen-
eity correlates w i th increased ventricular irritabil ity by programmed 
electrical stimulation and w i th an increment in cardiac mortality. 
These findings are consistent w i th data obtained during voltage 
mapping, and show the heterogeneity o f the scar in patients wi th 
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2.4 3D structure of HT: basis for the 
differentiation of patients with and without 
M V T 
Recent data obtained f rom animal and human studies in which scars 
detected by MRl were imported into navigation systems and 
merged wi th electro-anatomical maps have revealed that the MVT 
substrate is undoubtedly located inside the MRJ-detected scar and 
associated wi th HT. Ashikaga et d.?7 registered V T activation 
sequences 10—12 days after infarction wi th the 3D scar anatomy 
derived f rom high-resolution ceMR!. The authors used a porcine 
model of chronic myocardial infarction based on epicardial sock elec-
trodes or endocardial basket catheters, which are in direct contact 
w i th the part o f the myocardium where the electrical signal is 
recorded. MRl revealed a scar w i th spatially complex structures, par-
ticularly at the VT isthmuses. The re-entry isthmus was characterized 
by a relatively small volume of viable myocardium bound by the scar 
tissue. Codreanu et at. and Desjardins et a!, showed that critical 
sites o f post-infarction MVT arrhythmias were confined to scars 
detected by voltage mapping that overlapped w i th areas o f high SL 
Nevertheless, the MVT substrate inside the scar was not completely 
characterized in these studies. 
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In order t o gain fur ther insight into the MVT substrate. Perez-David 
et al?0 compared the architecture o f the scar and H T in a group of 
patients w i th MVT and in a matched contro l group. The scar, scar 
core, and H T were defined as the tissues showing an SI > 2 SD, > 3 
SD, and between 2 and 3 SD of remote normal tissue SI, respective-
ly.3 To determine the architecture of the HT, the authors examined 
consecutive short-axis slices, in which the H T was automatically col-
oured based on SI (Figure 3). These slices were evaluated t o deter-
mine the continuity of the H T and its connections t o normal 
myocardium. The H T usually surrounded the core o f the scar, but 
also formed corrí dor-l ike structures, through which HT passed 
f rom one side to the next by crossing the core of the scar and con-
necting t o normal tissue. These structures are known as H T channels 
(Figure 4). Al though no differences were observed regarding LVEF or 
necrotic mass, HT channels were more common in the MVT group 
than in the con t ro l group (88 vs. 33% of patients; P < 0.005). Most 
HT channels were located partly o r totally in the subendocardium. 
2.4.1 SI mapp ing 
A n SI map is a 3D map in which the average subendocardial or sub-
epicardial SI is projected on a shell that represents either the endocar-
dial or the epicardial surface of the left ventricle. The SI was colour 
F i g u r e 3 ceMRI characterization of the structure of heterogeneous tissue. Two short-axis slices of an anteroseptat myocardial infarction in a patient 
from the sustained monomorphic ventricular tachycardia group, showing the following features: (A) the unprocessed infarct zone (arrows indicate 
heterogeneous tissue); (6) an area with SI >2 SD: (C) an area with signal intensity > 3 SD (the core of the scarred area); and (D) the differences 
between (B and C) (SI >2 SD and < 3 SD). Heterogeneous tissue is shown in blue. Reproduced with permission f rom reference 40. 
F i g u r e 4 Identification of HT channels. Short-axis slices of a posterolateral myocardial infarction in a patient from the sustained MVT group. Notice 
the continuity of the HT in the successive short-axis slices, creating a corridor/channel that extends from the base to the apex. Whi te arrows show 
the HT channel (in blue). Reproduced with permission from reference 40. 
F i g u r e 5 Endocardial SI mapping from a patient with sustained 
monomorphic ventricular tachycardia (MVT) and an anteroseptal 
scar. For this process, the left ventricular endocardial/epicardial con-
tours were manually defined on contiguous short-axis slices, which 
were imported into a custom-developed tooL The average SI of 
the subendocardial tissue is projected onto the endocardial 
surface. The colour range provides information on subendocardial 
SI. as follows: the red area represents an SI > the minimal SI in 
the core of the scar; the magenta area represents normal myocar-
dium (SI < SI peak in normal myocardium); and the area between 
these extremes is the heterogeneous tissue. 
coded t o provide information on the distr ibution o f HT, and to deter-
mine the presence of SI channels that were defined as corr idors of 
continuous tissue differentiated by a lower SI f rom the surrounding 
scar tissue and connected to normal myocardium via at least one 
point (Figure 5, white arrowheads). 
2.4.2 C o m p a r i s o n of vo l tage and SI mapp ing in V T pat ients 
The comparison of voltage and SI maps showed a significant relation-
ship between infarct mass (SI > 2 SD) and scar extension defined by 
< 1.5 mV (R1, 0.4; P < 0.009). SI mapping showed the presence of 26 
channels In 17 o f 18 patients; these channels coincided In location and 
orientat ion wi th a corresponding C C in the voltage maps (Figure 6). 
Electrograms wi th IC/LP were recorded In the inner part of all chan-
nels. Similar results were recently reported by Andreu et ai., w h o 
compared SI and electro-anatomical mapping. O f the 16 C C observed 
w i th voltage mapping, 13 (81%) were identified on the 3D ceMRI-
derived scar reconstruction when only half of the subendocardial 
wal l was considered. These observations proved the association 
between IC/LP and HT and, consequently, the association between 
H T and VT substrate. 
2.4.3 Role o f SI mapp ing in t h e di f ferent iat ion o f pat ients 
w i t h and w i t h o u t V T 
The information afforded by SI mapping could prove useful for iden-
tifying patients at low risk o f ventricular arrhythmias.40 W h e n patients 
w i th and wi thout VT were compared, SI channels were more fre-
quently observed in patients w i th VT. Endocardial SI mapping 
detected channels in 94% o f patients in the sustained MVT group 
F i g u r e 6 Comparison of voltage and SI mapping. Endocardial voltage (A) and SI maps (8) from an inferolateral infarction. (A) The voltage map shows 
the extension of the scar when the voltage scar definition was set between 0.03 and 1.5 mV. Two corridors of higher voltage are easily identified inside 
the scar. (B) The SI map shows a similar distribution of the scar and a channel that runs parallel to the mitral annulus from segments 6 and 10 (white 
arrows), and a second channel perpendicular to the mitral annulus between segments 6 - 8 and 5 - 7 (black arrows). The colour range provides in-
formation on subendocardial SI, as in Figure 5. Reproduced with permission from reference 40. 
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and in only 55% of patients in the cont ro l group (Figure 7). In addit ion, 
complete SI channels, namely, those connected to normal tissue by 
t w o sites, were observed in 17 o f 18 patients in the VT group, but 
in only five in the cont ro l group. Therefore, the absence of SI channels 
could enable us t o identify low-risk patients, because almost all 
patients w i th MVT had SI channels. 
2.4.4 Future applications of SI mapping 
The ability t o quantify H T mass and to determine its structure 
non-invasively wi l l make it possible t o explore and compare new 
therapeutic strategies that could act on the progression of H T or 
H T components, such as fibroblasts/myofibroblasts or myocytes. 
Myocyte division is more intense at the border o f the scar, and, 
when combined w i th fibroblast proli feration, could influence progres-
sion of the V T substrate. 
A n integrated 3D scar reconstruction f rom ceMRI may facilitate VT 
ablations. SI mapping is free f rom the limitations o f voltage mapping, 
such as poor wal l -ca theter contact, far-field influences f rom normal 
myocardium, or, in the case of epicardial mapping, the presence of 
epicardial f a t A l l these limitations could lead to us t o underestimate 
scar dimensions. As SI mapping is free of these limitations, it provides 
an accurate delimitation of the scar. Although most VT circuits are 
located in the endocardium, some VTs are only approachable f rom 
the epicardium. SI mapping could contr ibute t o the identification of 
epicardial VT substrate before the electrophysiological study, thus en-
abling the ablation strategy to be planned before the procedure. A l -
though most patients requiring V T ablations have ICDs, 
defibril lators are still considered a contraindication for MRI. A l -
though early reports demonstrated potential software and hardware 
failure, w i th clinical complications, more recent studies show that 
ceMRI can be performed safely in selected 1CD patients. N o t 
only can MRI be performed safely in patients wi th ICD, but 3 D MRI 
scar maps can be extracted and registered successfully, and provide 
important information on complex scar anatomy. 
3. V T substrate In non-ischaemic 
cardiomyopathy 
3.1 Scar characteristics in patients with 
sustained MVT during electro-anatomical 
mapping 
VT in non-ischaemic cardiomyopathy is most commonly the result of 
myocardial re-entry associated wi th scar tissue. Soejima et at. 
demonstrated the presence o f this mechanism in 22 of 26 patients 
wi th monomorph ic VT. Al l patients w i th myocardial re-entry had 
endocardial scar tissue (20 o f 20 patients) and/or epicardial scar 
tissue (seven of seven patients mapped). Most scars were adjacent 
t o a valve annulus, and may be greater in extent on the epicardium 
than on the endocardium. O f the 19 V T circuit isthmuses identified, 
12 were associated w i th an endocardial scar and seven w i th an epicar-
dial scar. 
The results reported by Hsia ei at. are consistent w i th the findings 
presented above.50 The authors performed left ventricular endocar-
dial electro-anatomical mapping in 19 patients wi th non-ischaemic 
cardiomyopathy and MVT. A l l patients had abnormal low-voltage 
endocardial areas located near the base o f the ventricle in the per i -
valvular region. Most (88%) o f the 57 mapped VTs originated f rom 
the base of the ventricle, at sites corresponding to regional scars. 
These catheter mapping studies of patients w i th non-ischaemic 
















F i g u r e 7 Comparison of SI maps between patients with and without sustained MVT. (A) Endocardial SI mapping in a patient with MVT. Notice the 
presence of multiple SI channels, (fi) Endocardial SI mapping in a patient from the control group. Notice the absence o f SI channels. The colour range 
provides information on subendocardial SI, as in Figure 6. 
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re-entry around scar tissue deep in the myocardium near the base o f 
the ventricle and in the perivaivular region. 
3.2 Character izat ion of the scar by MRI 
Data obtained using ceMRI in patients w i th an I C D provided similar 
information to that of voltage mapping in MVT patients. In 26 patients 
w i th non-ischaemic cardiomyopathy, the transmural extent of scar 
tissue as a percentage of wall thickness was calculated in myocardial 
slices. The predominance of scar tissue involving 26—75% o f wall 
thickness was significantly predictive o f inducible VT, and remained in-
dependently predictive in the multivariate model after adjustment for 
LVEF. This study suggested that mid-wall myocardial enhancement in-
volving > 2 5 % of wal l thickness is the substrate for sustained VT in 
non-ischaemic cardiomyopathy. 
3.2.1 ceMRI and spontaneous V T 
Approximately 30% of patients wi th dilated cardiomyopathy have 
mid-wall fibrosis, as detected by ceMRI. Regional fibrosis can increase 
susceptibility t o arrhythmia and progression o f heart failure. The prog-
nostic implications of mid-wall fibrosis in patients wi th dilated cardio-
myopathy were analysed in a prospective study that included 101 
consecutive patients. The fibrosis present in 35% o f patients was asso-
ciated w i th a higher rate o f hospitalization for a cardiovascular condi-
t ion and tota l mortali ty. Multivariate analysis identified mid-wall 
fibrosis as the sole independent predictor of death or hospitalization. 
Mid-wall fibrosis was also an independent predictor of sudden cardiac 
death or VT after correct ion for baseline differences in LVEF.52 
Similar results were recently repor ted by lies et atj3 w h o p ro -
spectively enrolled 103 patients wi th criteria f o r primary prevention 
of sudden cardiac death. ceMRI was performed before placement o f 
the ICD, and identified regional fibrosis in 5 1 % of patients wi th 
non-ischaemic cardiomyopathy and in all 42 patients wi th ischaemic 
cardiomyopathy. There was a 14% discharge rate in the ¡schaemic car-
diomyopathy group {six o f 42). Although no ICD discharges were 
observed in the non-ischaemic cardiomyopathy group w i thou t region-
al fibrosis, 29% of patients wi th regional fibrosis received ICD shocks. 
The LVEF was similar in patients wi th and w i thou t device therapy 
(24 + 12 vs. 26 +• 8%, P NS) and those wi th or w i thout regional f i -
brosis (25 + 9 vs. 26 + 9%, P NS). 
4. Conclusions 
H T is a consequence o f the remodell ing process, in which surviving 
myocytes, fibroblasts/myofibroblasts, and the extracellular matr ix 
interact mechanically and electrically t o fo rm the V T substrate. 
ceMRI makes it possible t o determine the size and 3D structure o f 
the scar and HT. This information could be useful when evaluating 
new therapies focused on the cont ro l o f remodell ing processes and 
risk stratification in patients wi th structural heart disease. 
5. Clinical implication 
Non-invasive identification and characterization o f VT substrate could 
facilitate the identif ication of patients at risk of ventricular arrhyth-
mias. This information should be assessed in large mult icentre 
studies and compared w i th other predictors of cardiac mortal i ty, 
such as functional and volume parameters o f the left ventricle. Screen-
ing o f patients for primary prevention of sudden cardiac death could 
be improved by the analysis of the scar characteritics. In addit ion, non-
invasive identification o f VT substrate could improve the ablation 
procedure. 
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